Effect of a diuretic adjustment algorithm and nonpharmacologic management in patients with heart failure: study

Maria Karolina Echer Ferreira Feijó1, Andreia Biolo2,3, Karen Brasil Ruschel4

  • 1School of Nursing, Graduate Program Federal University of Rio Grande do Sul, São Manoel, 963 - Rio Branco, Porto Alegre, RS, 90620-110, Brazil. mariakarolinafeijo@gmail.com.

Trials
|April 18, 2015
PubMed

Insights

This study will assess the Algoritmo de Ajuste de Diurético (AAD) and non-pharmacologic management to improve heart failure (HF) clinical stability and reduce 90-day hospital readmissions. The AAD aims to optimize diuretic dosage for better HF patient outcomes.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Pharmacology

Background:

  • Heart failure (HF) management faces challenges in achieving clinical stability and reducing hospital readmissions.
  • The Diuretic Treatment Algorithm (DTA), validated in Brazil as the Algoritmo de Ajuste de Diurético (AAD), is feasible but its clinical outcome impact is unassessed.
  • A randomized trial protocol is described to evaluate the AAD's effectiveness in improving HF patient outcomes.

Purpose of the Study:

  • To assess the effectiveness of the AAD algorithm combined with non-pharmacologic management.
  • To improve clinical stability in patients with heart failure.
  • To reduce the 90-day hospital readmission rate in heart failure patients.

Main Methods:

  • Prospective randomized open blinded endpoint (PROBE) parallel-group trial design.
  • Adult patients with reduced ejection fraction HF recruited from a specialized HF clinic.
  • Intervention group: AAD for diuretic adjustment and weekly calls for non-pharmacologic management reinforcement; Control group: standard physician adjustment and no calls.
  • Study endpoints: 90-day readmission/emergency department visits for HF decompensation and clinical instability.

Main Results:

  • The trial is designed to assess the effectiveness of the AAD and non-pharmacologic management.
  • The study aims to identify early signs of clinical deterioration.
  • The combined intervention seeks to reduce emergency department visits and readmission rates.

Conclusions:

  • This trial will evaluate the combined impact of the AAD algorithm and non-pharmacologic strategies.
  • The study will determine the efficacy of this intervention in managing heart failure decompensation.
  • Outcomes will focus on reducing emergency care utilization and hospital readmissions.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
571
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
602
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
552
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
746